Cholecystokinin Receptor Antagonists
Overview
Authors
Affiliations
Since 1979 three classes of cholecystokinin receptor antagonists have been described: 1) derivatives of cyclic nucleotides, 2) derivatives of amino acids, and 3) C-terminal fragments or partial sequences of cholecystokinin. These various antagonists share a number of common features, such as their specific, reversible, and competitive actions, but they vary in the potency with which they inhibit the actions of cholecystokinin.
Effect of intravenous infusion of proglumide on ruminal motility in conscious sheep (Ovis aries).
Onaga T Vet Res Commun. 2007; 31(8):1021-36.
PMID: 17279465 DOI: 10.1007/s11259-006-0164-z.
Pathogenesis of the impaired gall bladder contraction of coeliac disease.
Brown A, Bradshaw M, Richardson R, Wheeler J, Harvey R Gut. 1987; 28(11):1426-32.
PMID: 3428667 PMC: 1433691. DOI: 10.1136/gut.28.11.1426.
Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokinin.
Evans B, Bock M, Rittle K, DiPardo R, Whitter W, Veber D Proc Natl Acad Sci U S A. 1986; 83(13):4918-22.
PMID: 3014519 PMC: 323855. DOI: 10.1073/pnas.83.13.4918.
Otsuki M, Nakamura T, Okabayashi Y, Fujii M, Tani S, Fujisawa T Dig Dis Sci. 1989; 34(8):1249-56.
PMID: 2473869 DOI: 10.1007/BF01537274.
Perspectives of CCK antagonists in pancreatic research. Part II. Experimental studies.
Takacs T, Pap A Int J Pancreatol. 1991; 10(1):1-8.
PMID: 1757727 DOI: 10.1007/BF02924248.